People · Operator
Named in public records as an officer, director or promoter · active 2009–2016 · Other Technology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Omniox, Inc. | — | Other Technology | Series B | $39.4M | $732.9M | 2012 |
| Handa Pharmaceuticals, LLC | — | Pharmaceuticals | Seed | $2.0M | $77.7M | 2009 |
Stephen Cary at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen Cary on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeff Samberg | 1 | 5 |
| Ajit Shah | 1 | 3 |
| John Wesley | 1 | 2 |
| Mitchell S. Mutz | 1 | 1 |
| Jonathan Winger | 1 | 1 |
| Fang-yu Liu | 1 | 1 |
| Meifang Chang | 1 | 1 |
| Jonathan Embleton | 1 | 1 |
| Jeffrey S. Samberg | 1 | 1 |
| Laurence S. Marton | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.